Jefferies cuts Hawaiian Electric stock price target on revenue uncertainty

Jefferies cut its Hawaiian Electric price target to $11.75 from $13.75 while keeping an Underperform rating, citing that only ~$85 million of a $170 million revenue reset request adds to earnings. While Hawaii approved the process, the revenue amount decision is expected in mid-to-late April 2027, and three settlement payments of $479 million each remain unfunded, with financing expected to absorb much of the recovery. The stock trades at $13.63 (~12.5x 2028E EPS of $1.09) and is flagged as above fair value, despite a low PEG of 0.17; recent Q1’26 EPS of $0.18 missed the $0.28 forecast due to storm-related costs.

Analysis

The market is treating this as a de-risking event, but the economic value unlock is still capped by capital structure, not by the rate-case headline. When only a portion of the requested uplift is actually earnings-accretive, the upside to common equity becomes highly convex to financing terms: a cheaper recovery schedule helps, but any debt/equity issuance or higher borrowing cost can absorb most of the benefit. That makes HE more of a balance-sheet and regulatory-process trade than a pure utility rerating.

Near term, the bigger catalyst is not the eventual allowed revenue figure in 2027; it is whether management can fund the remaining settlement obligations without a punitive dilution overhang or a credit downgrade. If lenders demand tighter covenants, the equity can underperform even if regulators remain constructive, because the market will start discounting recovery leakage through interest expense and future ROE compression. That also limits sympathy for the rest of the regulated utility complex: this is idiosyncratic, not a broad XLU signal.

Contrarian view: the rally may be partially justified because the tail risk of an outright disaster scenario is being reduced, but the move can still be overdone if investors are implicitly pricing an earnings step-up that does not exist. The stock can grind higher only if the funding solution is cleaner than expected; otherwise, this is a classic case where headline relief does not translate into commensurate per-share value. Watch for any signs of financing, rating pressure, or equity issuance as the real falsifiers.

Key Decisions for Investors

• Tactically short HE or buy 3-6 month put spreads into strength; thesis is that the current rerating is ahead of cash-flow reality, with a practical downside target back toward the low-$11s if funding terms disappoint.
• Pair trade: short HE vs long XLU or a high-quality regulated utility name over the next 1-3 months to isolate idiosyncratic settlement/financing risk from the broader utility factor.
• If already long HE, hedge immediately with puts rather than selling outright; the main risk is a refinancing/dilution headline, not day-to-day operating miss, so optionality is the cleaner protection.
• Set a hard alert on any credit rating action, debt issuance, or equity raise; those are the events that would invalidate a short thesis and likely trigger another squeeze higher.